Overcoming skin's barrier: the search for effective and user-friendly drug delivery.

Although hypodermic needles rapidly deliver large doses of drugs such as insulin across the skin for systemic administration, the pain, local trauma, and difficulty to achieve sustained or complex delivery profiles has motivated development of novel alternative technologies. Microneedles, jet injectors, and thermal poration make micron-scale holes in skin through which drugs can be driven in a user-friendly manner. Chemical enhancers, iontophoresis, electroporation, and ultrasound increase skin permeability by making submicron alterations in skin microstructure for continuous delivery over time.

[1]  C. Weller,et al.  Jet injection of insulin vs the syringe-and-needle method. , 1966, JAMA.

[2]  W. Warwick,et al.  Evaluation of a cystic fibrosis screening system incorporating a miniature sweat stimulator and disposable chloride sensor. , 1986, Clinical chemistry.

[3]  L. John,et al.  Blood glucose control in diabetic rats by transdermal iontophoretic delivery of insulin , 1988 .

[4]  A Survey of Patient Preference for Insulin Jet Injectors Versus Needle and Syringe , 1992, The Diabetes educator.

[5]  Howard I. Maibach,et al.  Evaluation of the Barrier Function of Skin Using Transepidermal Water Loss (TEWL): A Critical Overview , 2014 .

[6]  S. Mitragotri,et al.  Ultrasound-mediated transdermal protein delivery , 1995, Science.

[7]  M. Prausnitz.  Reversible skin permeabilization for transdermal delivery of macromolecules. , 1997, Critical reviews in therapeutic drug carrier systems.

[8]  V. Préat,et al.  Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[9]  M. Allen,et al.  Microfabricated microneedles: a novel approach to transdermal drug delivery. , 1998, Journal of pharmaceutical sciences.

[10]  A. Peer,et al.  Fentanyl Delivery from an Electrotransport System: Delivery is a Function of Total Current, Not Duration of Current , 1998, Journal of clinical pharmacology.

[11]  R. Langer,et al.  Drug delivery and targeting. , 1998, Nature.

[12]  M. Prausnitz,et al.  A practical assessment of transdermal drug delivery by skin electroporation. , 1999, Advanced drug delivery reviews.

[13]  L. Jovanovic,et al.  Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team. , 1999, JAMA.

[14]  J. Weaver,et al.  Creation of transdermal pathways for macromolecule transport by skin electroporation and a low toxicity, pathway-enlarging molecule. , 1999, Bioelectrochemistry and bioenergetics.

[15]  Modern insulin therapy for type 1 diabetes mellitus. , 1999, Primary care.

[16]  B. Bellhouse,et al.  Transdermal and transmucosal powdered drug delivery. , 1999, Critical reviews in therapeutic drug carrier systems.

[17]  M. Allen,et al.  Microfabricated microneedles for gene and drug delivery. , 2000, Annual review of biomedical engineering.

[18]  Samir Mitragotri,et al.  Transdermal monitoring of glucose and other analytes using ultrasound , 2000, Nature Medicine.

[19]  K. Kirchhoff,et al.  Comparing two methods of topical anesthesia used before intravenous cannulation in pediatric patients. , 2000, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.

[20]  Mark G. Allen,et al.  Lack of pain associated with microfabricated microneedles. , 2001 .

[21]  F. Pass,et al.  Delivery of insulin by jet injection: recent observations. , 2001, Diabetes technology & therapeutics.

[22]  Rebecca S. Shawgo,et al.  BioMEMS for drug delivery , 2002 .